Main Page/Hyperlinks

From COVID-19
Jump to navigation Jump to search


Wikipedia Article on COVID-19

Study on Blood-type and COVID-19 Infection and Severity

Mitigation Strategy

Possible Patient Zero

WHO China Joint Mission Report

New Coronavirus May Spread as an Airborne, Aerosol like SARS

The Dos and Don’ts of ‘Social Distancing’

WHO Expert: Singapore Wins Praise for its COVID-19 Strategy. The U.S. Does Not.

Practice Advisory: Novel Coronavirus 2019 (COVID-19)

Features, Evaluation and Treatment of COVID-19

COVID-19: Why won't the WHO officially declare a coronavirus pandemic?

Worldwide COVID-19 Pandemic Infection Case Counts

Efficacy of Zinc ion in inhibiting SARS-CoV replication and activity of RNA dependent RNA Polymerase

Efficacy of Hydroxychloroquine in treating SARS-CoV-2 infection:

Early Strains and Evolution of Virus

Phylogeny of SARS-CoV-2 Strains

NCBI Genome Sequences

UniProt Proteomes

INO-4800 Vaccine Candidate

mRNA-1273 Vaccine Candidate Clinical Trials and Descriptions

Ho V. California launches nation’s first disaster relief fund for undocumented immigrants.

Remdesivir Efficacy

How long virus is sustainable on various surfaces

EPA Disinfectants for Use against SARS-CoV2

MERS-CoV in Camels but Not Camel Handlers, Sudan, 2015 and 2017

COVID-19 statistics: What medical resources are needed to treat the coronavirus?

SARS-CoV-2 spike proteins bind to ACE2 inhibitors to gain intracellular entry and TMPRSS2 inhibitors reduced entry

Clinical characteristics of 138 hospitalized COVID-19 patients from Wuhan

Coronavirus Disease 2019 (COVID-19): Get Your Home Ready

Proclamation on Declaring a National Emergency Concerning the Novel Coronavirus Disease (COVID-19) Outbreak

Mannose-Binding Lectin Gene Polymorphisms and their association with SARS-CoV infections (SARS)

Lancet article hypothesizing ARB usage upregulates ACE2, worsening severity of COVID-19 infection

European Society of Cardiology Response and Recommendation for Continued Use of ARBs

Clinical trials for therapeutics targeting coronavirus

Johns Hopkins University Coronavirus Resource Center

Fast Facts on U.S. Hospitals

Summary of Compiled Study Results on Chloroquine Efficacy in Treating COVID-19

Marseille Drug Trial Preliminary Results

Handbook of Covid-19 Prevention and Treatment (China)

APN01 Clinical Trial Press Release

Favipiravir Drug Trial Press Release in China (March 17, 2020)

ENT U.K. Report on Loss of Sense of Smell and Taste as Symptom of COVID-19 Infection

Rembault Report on phylogenetic analysis of nCoV-2019 genomes (March 6, 2020)

FDA Guidance on Conduct of Clinical Trials of Medical Products during COVID-19 Pandemic. Guidance for Industry, Investigators, and Institutional Review Boards. March 2020

FDA News Release Concerning Warning Letters Sent to 7 Companies Fraudulently Selling Covid-19 Treatments

U.S. Clinical Trials

Phases of Disaster

Enforcement Discretion for Telehealth Remote Communications During the COVID-19 Nationwide Public Health Emergency

Crisis Leadership and Communications to Navigate the Coronavirus For Public Officials

American Psychological Association: Coping Resources

CDC Coping with Disaster or a Traumatic Event

Medicare Reimbursement Expansion for Telehealth

HHS Announcement Encouraging the Use of Telehealth for Healthcare Workers

Medicare Telemedicine Healthcare Provider Fact Sheet

American College of Cardiology Bulletin for COVID-19 Patient Care

Rapid Expert Consultation on the Possibility of Bioaerosol Spread of SARS-CoV-2 for the COVID-19 Pandemic:

Release from Cytodyn Concerning Results of Leronlimab Administration in 7 Patients:

SARS-CoV-2 Viral Load and the Severity of COVID-19, Correspondence from the Oxford COVID-19 Evidence Service Team (of the Center of Evidence-Based Medicine

NY COVID-19 Reported Case and Death Data 1 2 3

NY COVID-19 Reported Case and Death Data by Borough Data 1 2

CDC Age and Sex Reported U.S. Deaths due to COVID-19, Influenza, and Pneumonia

Athersys Multistem Therapy Trial Approval

Nexus GitHub Code and Data

Stay-at-Home and Shelter-in-Place Advisories or Orders by State

Proximal Origin of SARS-CoV-2

WHO - Ten threats to global health in 2019

Regeneron - Regeron’s REGN-COV2 Antibody Cocktail Reduced Viral Levels and Improved Symptoms in Non-Hospitalized COVID-19 Patients.

Retraction Watch. Retracted coronavirus (COVID-19) papers.

ASTRO Hyperlinks

The American Society for Radiation Oncology (ASTRO) has compiled the following health resources, including guidance to keep medical facilities and patients safe during the pandemic:

   1. American College of Surgeons (ACS)
   2. American Medical Association (AMA). COVID-19 resource center for physicians
       a. CMS payment policies and regulatory flexibilities
   3. American Society for Clinical Oncology (ASCO). Coronavirus Resources
   4. American Society for Radiation Oncology (ASTRO)
       a. Coronavirus Updates on ASTRO Activities
       b. Radiation Therapy (RT) Answers
       c. Radiation Oncology (ROhub). Member Coronavirus Conversations
       d. Patient Communication. Sample Letter to Patients 
       e. Health and Human Services (HHS). Directive to States 
   5. Centers for Disease Control and Prevention (CDC) 
   6. Centers for Medicare and Medicaid Services (CMS). COVID-19 Public Health Emergency 
   7. European Society for Radiotherapy and Oncology Statement (ESTRO) 
   8. French Health Ministry High Council for Public Health (HCSP) 
   9. World Health Organization (WHO) 
       a. Coronavirus: 
       b. COVID-19